市場調查報告書

智慧胰島素筆針的全球市場:市場機會,市場分析,市場佔有率,及未來預測

Global Smart Insulin Pens Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 526714
出版日期 內容資訊 英文 190 Pages
商品交期: 請詢問到貨日
價格
Back to Top
智慧胰島素筆針的全球市場:市場機會,市場分析,市場佔有率,及未來預測 Global Smart Insulin Pens Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023
出版日期: 2017年07月01日內容資訊: 英文 190 Pages
簡介

本報告涵括智慧胰島素筆針的全球市場,總括性檢驗推動市場成長要素,阻礙因素,市場機會,市場競爭情形等,並進行目前市場方案分析與2023年為止的市場預測。

第1章 序論

  • 摘要整理
  • 市場評估手法

第2章 市場概要

  • 智慧胰島素筆針的全球市場:演進與變化
  • 市場定義及範圍
  • 產業結構
  • 相關法規
  • 全體市場分析
    • 主要5項重要調查結果
    • 市場機會前5項
    • 主要5公司
    • 競爭策略前3項
  • 市場預算分析
  • 策略性分析
    • 投資 vs. 引進模式
    • 全方位產業分析
    • 波特的五力分析模型
    • 專利分析
    • Seesaw分析
    • 消費者分析及主要購買標準
  • 市場競爭分析
    • 重要策略與分析
    • 市場佔有率及龍頭企業分析
  • 策略性建議及重要的結論事項
    • 各地區投資機會
    • 針對新用途的市場機會
    • 達到最快成長領域的投資機會

第3章 市場決策要素

  • 推動市場成長要素
  • 阻礙市場成長要素
  • 市場機會
  • 市場課題

第4章 市場分類

  • 智慧胰島素筆針的全球市場網絡不同連線方式分析
    • 市場定義及範圍
    • 支援決策所需的資料庫及評估手法
    • 市場領域間比較分析
    • 市場機會矩陣
    • 市場分類
  • 智慧胰島素筆針的全球市場各適應症分析
    • 市場分類
  • 智慧胰島素筆針的全球市場各流通管道分析
    • 市場分類

第5章 市場競爭情形

  • 主要策略

第6章 各地區分析

  • 地區市場分類
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第7章 主要企業簡介

目錄
Product Code: HME-6080717

The smart insulin pens market is expected to grow with a CAGR of around 18% during the forecast period 2016-2023. The rising prevalence of diabetes is one of the major factor which is increasing the growth of global smart insulin pens market. As per international diabetes federation, it is expected that around 642 million people are expected to suffer from diabetes around the world by the end of 2040. Hence, the growing concern for continuous glucose monitoring for diabetic patients is rising the demand smart insulin devices. Factors such as lack of dose flexibility and privacy and security concern are major challenges restricting the growth of smart insulin pens market.

Geographically,. North America held the highest revenue share in 2016 in smart insulin pens market. The growth in North America market is majorly driven by the increasing adoption of smart glucose monitoring devices and rising prevalence of diabetes in the North America. The Asia Pacific smart insulin pen market is expected to grow with an impressive CAGR during the forecasted period 2016-2023. The growth in the region is mainly driven by rising adoption of smart devices for glucose monitoring which helps to maintain the sugar level of patients. Furthermore, presence of diabetic patient pool in Asian countries such as India, China, Japan, etc. is also contributing to growth in Asia Pacific smart insulin pens market.

The key players of insulin pens market who are actively working for the development of new technology are Abbott(U.S.), Companion Medical Inc. (U.S.), Elli Lilly (U.S.), Emperra Gmbh (Germany), Medtronic's (U.S.) and Jiangsu Delfu Medical Device Co. (China) etc. all such players are adopting various strategic initiative such as product development, investment, research and development, expansion, etc. to sustain in the dynamic market.

The smart insulin pen market is segmented on the basis of connectivity, indication, channel and geography. Based on connectivity global smart insulin pens market report segment includes bluetooth connected smart insulin pens and USB connected smart insulin pens. Bluetooth connected smart insulin pens held the highest revenue share in connectivity segment. The Bluetooth connectivity feature permits automatic insulin data sharing to healthcare providers. The sharing of insulin data automatically helps to track and monitor the patients sugar level. Hence, the features of Bluetooth connected smart insulin pens is boosting the growth in the global smart insulin pens market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL SMART INSULIN PENS MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. PATENT ANALYSIS
    • 2.7.5. SEE-SAW ANALYSIS
    • 2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES & ANALYSIS
    • 2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISING PREVALENCE OF DIABETES
    • 3.1.2. RISING DEMAND FOR DIABETES MANAGEMENT
    • 3.1.3. EXPLOSION OF BLUETOOTH CONNECTED INSULIN PEN
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. PRIVACY AND SECURITY CONCERNS
    • 3.2.2. LACK OF DOSE FLEXIBILITY
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. NEEDLE STICK INJURIES
    • 3.3.2. INCREASING ADOPTION OF MEDICAL MANAGEMENT PROCESS
    • 3.3.3. GROWING DEMAND FOR PERSONALIZED OR PATIENT CENTRIC DEVICES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. HIGH COST OF SMART PENS
    • 3.4.2. LOW ACCURACY CONCERNS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL SMART INSULIN PENS MARKET BY CONNECTIVITY
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET
        • 4.1.5.1.1. APPLICATION
        • 4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET
        • 4.1.5.2.1. APPLICATION
        • 4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. KEY CONCLUSIONS
  • 4.2. GLOBAL SMART INSULIN PENS MARKET BY INDICATION
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL TYPE 1 DIABETES MARKET
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL TYPE 2 DIABETES MARKET
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
  • 4.3. GLOBAL SMART INSULIN PENS MARKET BY CHANNEL
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL E-COMMERCE MARKET
        • 4.3.5.2.1. APPLICATION
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. GLOBAL RETAIL PHARMACIES MARKET
        • 4.3.5.3.1. APPLICATION
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS & ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL SMART INSULIN PENS MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRIAL END-USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ABBOTT
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
    • 7.1.6. STRATEGIC ANALYSIS
  • 7.2. COMMON SENSE INC.
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
    • 7.2.6. STRATEGIC ANALYSIS
  • 7.3. COMPANION MEDICAL INC
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
    • 7.3.6. STRATEGIC ANALYSIS
  • 7.4. DEXCOM
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
    • 7.4.6. STRATEGIC ANALYSIS
  • 7.5. DIABNEXT
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
    • 7.5.6. STRATEGIC ANALYSIS
  • 7.6. DIGITAL MEDICS PTD LTD
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
    • 7.6.6. STRATEGIC ANALYSIS
  • 7.7. ELLI LILLY
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
    • 7.7.6. STRATEGIC ANALYSIS
  • 7.8. EMPERRA GMBH
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
    • 7.8.6. STRATEGIC ANALYSIS
  • 7.9. INNOVATION ZED
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
    • 7.9.6. STRATEGIC ANALYSIS
  • 7.10. MEDTRONIC'S
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
    • 7.10.6. STRATEGIC ANALYSIS
  • 7.11. PENDIQ GMBH
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
    • 7.11.6. STRATEGIC ANALYSIS
  • 7.12. SANOFI
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
    • 7.12.6. STRATEGIC ANALYSIS
  • 7.13. SMARTPLUS
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
    • 7.13.6. STRATEGIC ANALYSIS
  • 7.14. TANDEM DIABETES CARE
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
    • 7.14.6. STRATEGIC ANALYSIS
  • 7.15. OTHERS
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS
    • 7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL SMART INSULIN PENS MARKET BY CONNECTIVITY 2014-2023 ($ MILLION)
  • 2. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL SMART INSULIN PENS MARKET BY INDICATION 2014-2023 ($ MILLION)
  • 5. GLOBAL TYPE 1 DIABETES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 6. GLOBAL TYPE 2 DIABETES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL SMART INSULIN PENS MARKET BY CHANNEL 2014-2023 ($ MILLION)
  • 8. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 9. GLOBAL E-COMMERCE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL RETAIL PHARMACIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. NORTH AMERICA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 12. EUROPE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 13. ASIA PACIFIC SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 14. REST OF THE WORLD SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BLUETOOTH CONNECTED SMART INSULIN PEN MARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL USB CONNECTED SMART INSULIN PEN MARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL TYPE 1 DIABETES MARKET 2014-2023 ($ MILLION)
  • 4. GLOBAL TYPE 2 DIABETES MARKET 2014-2023 ($ MILLION)
  • 5. GLOBAL CLINICS AND AMBULATORY SURGICAL CENTERS MARKET 2014-2023 ($ MILLION)
  • 6. GLOBAL E-COMMERCE MARKET 2014-2023 ($ MILLION)
  • 7. GLOBAL RETAIL PHARMACIES MARKET 2014-2023 ($ MILLION)
  • 8. UNITED STATES (U.S.) SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 9. CANADA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 10. UNITED KINGDOM (UK) SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 11. FRANCE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 12. GERMANY SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 13. SPAIN SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 14. ROE SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 15. INDIA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 16. CHINA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 17. JAPAN SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 18. AUSTRALIA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 19. ROAPAC SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 20. LATIN AMERICA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
  • 21. MENA SMART INSULIN PENS MARKET 2014-2023 ($ MILLION)
Back to Top